Company / Book Value per Share
Charles River Laboratories Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$64.3
FY2025
5-year range
$50.934 / $70.605
FY2021-FY2025
Trend
-4.6%
vs FY2024
Sector context
#19 of 159
Health Care
What the data says
Charles River Laboratories's book value per share of $64.3 is higher than 88% of companies in the Health Care sector (FY2025). Declined from $70.605 to $64.3 over the past 2 years.
Based on SEC 10-K filings.
$64.3 in FY2025 with a 5-year CAGR of +8.3%. Top quartile in the Health Care sector.
Declined from $70.605 to $64.3 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +2.9%
- 5-Year CAGR
- +8.3%
- 10-Year CAGR
- -
Sector benchmark
Top 12% in Health CareTop 12% of 159This company $64.3 Sector average $48.296
▼
+33.1% above sector average
Key checks
Key Insights
- 5-year CAGR of +8.3%, indicating consistent growth.
- In FY2025, book value per share decreased 4.6% year-over-year.
- Ranks #19 out of 159 companies in the Health Care sector.
- Peak book value per share was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $64.3 | -4.6% |
| FY2024 | $67.426 | -4.5% |
| FY2023 | $70.605 | +19.8% |
| FY2022 | $58.96 | +15.8% |
| FY2021 | $50.934 | +17.9% |
| FY2020 | $43.212 | +27.4% |
| FY2019 | $33.906 | +22.0% |
| FY2018 | $27.791 | +25.9% |
| FY2017 | $22.065 | +23.1% |
| FY2016 | $17.919 | +15.7% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026